Validation of the Cyberchondria Severity Scale (CSS): replication and extension with bifactor modeling

Journal of Anxiety Disorders
Aaron M NorrNorman B Schmidt

Abstract

Internet help seeking behaviors are increasingly common. Despite the positives associated with technology, cyberchondria, or the process of increased anxiety in response to internet medical information seeking, is on the rise. The Cyberchondria Severity Scale (CSS) was recently developed to provide a valid measure of cyberchondria across multiple dimensions. The current study sought to extend previous work on the CSS factor structure by examining a bifactor model. Participants (N=526) from a community sample completed the CSS via online crowd sourcing. Results revealed that the bifactor model of the CSS provided superior fit to the data, suggesting that it is useful to conceptualize the CSS as containing a General Cyberchondria factor that is orthogonal to its subfactors. Similar to previous work, the CSS Mistrust factor does not appear to be necessary to this construct. Finally, results revealed unique relations between General and Specific Cyberchondria factors with lower-order health anxiety dimensions.

References

Mar 1, 1990·Psychological Bulletin·P M Bentler
Mar 17, 2005·Psychological Assessment·Susan L LongleyRussell Noyes Jr
Apr 26, 2008·Health Policy·Marc LemireGuy Paré
Mar 1, 2011·Journal of Anxiety Disorders·Nicole M AlbertsHeather D Hadjistavropoulos
May 10, 2011·Cyberpsychology, Behavior and Social Networking·Susanne E Baumgartner, Tilo Hartmann
Feb 2, 2013·Expert Review of Neurotherapeutics·Vladan Starcevic, David Berle
Sep 21, 2013·Multivariate Behavioral Research·Steven P Reise
Feb 11, 2014·Journal of Anxiety Disorders·Eoin McElroy, Mark Shevlin
May 14, 2014·Journal of Behavior Therapy and Experimental Psychiatry·Aaron M NorrNorman B Schmidt
Dec 9, 2014·Journal of Affective Disorders·Aaron M NorrNorman B Schmidt

❮ Previous
Next ❯

Citations

Mar 5, 2016·International Journal of Behavioral Medicine·Antonia BarkeBettina K Doering
Jan 17, 2016·Annual Review of Clinical Psychology·Jesse Chandler, Danielle Shapiro
Oct 3, 2015·Psychiatry Research·Aaron M NorrNorman B Schmidt
Dec 9, 2014·Journal of Affective Disorders·Aaron M NorrNorman B Schmidt
Jul 15, 2016·Trends in psychiatry and psychotherapy·Fernanda Gonçalves da SilvaAdriana Cardoso
May 11, 2017·Psychotherapy and Psychosomatics·Vladan Starcevic
Jan 11, 2017·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Sabrina Cipolletta, Damiano Mocellin
Jun 18, 2017·Clinical Psychology & Psychotherapy·Thomas A Fergus, Marcantonio M Spada
Apr 24, 2019·Cyberpsychology, Behavior and Social Networking·Eoin McElroyMark Shevlin
Jun 21, 2019·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Burcin BekenMehtap Yazicioglu
Aug 8, 2019·Clinical Orthopaedics and Related Research·Julia BlackburnAna-Maria Vranceanu
Mar 14, 2020·Clinical Psychology & Psychotherapy·Claudia MarinoMarcantonio M Spada
May 17, 2018·Journal of Medical Internet Research·Perrine CréquitPhilippe Ravaud
May 18, 2019·The Psychiatric Quarterly·Vladan StarcevicKirupamani Viswasam
Nov 26, 2019·Clinical Orthopaedics and Related Research·Julia BlackburnAna-Maria Vranceanu
Nov 19, 2021·Journal of Medical Internet Research·Sandra K SchenkelMichael Witthöft

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.